A critical breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in many forms of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research